VF
VIR icon

Virtu Financial’s Vir Biotechnology VIR Stock Holding History

Virtu Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
+24,241
New +$193K 0.01% 988
2025
Q1 		– Sell
-12,836
Closed -$94K – 2077
2024
Q4 		$94K Buy
+12,836
New +$101K 0.01% 1035
2024
Q3 		– Sell
-25,428
Closed -$226K – 1921
2024
Q2 		$226K Buy
+25,428
New +$244K 0.02% 663
2022
Q2 		– Sell
-21,318
Closed -$548K – 2114
2022
Q1 		$548K Buy
21,318
+11,538
+118% +$342K 0.04% 363
2021
Q4 		$409K Buy
9,780
+1,301
+15% +$51K 0.04% 461
2021
Q3 		$369K Buy
+8,479
New +$367K 0.03% 611
2020
Q3 		– Sell
-23,306
Closed -$955K – 1548
2020
Q2 		$955K Buy
+23,306
New +$782K 0.11% 196

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Virtu Financial's VIR Position: Q1 2026 in Review

Virtu Financial opened a new position in Vir Biotechnology (VIR) in Q1 2026: 24,241 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #988 among its holdings. This is a return to the name: Virtu Financial previously reported a position in VIR as recently as Q4 2024.

Virtu Financial first reported a position in VIR in Q2 2020 and has held it in 7 quarters since. The position peaked at $955K in Q2 2020. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Virtu Financial held 24,241 shares of Vir Biotechnology worth $217K as of Q1 2026.
  • Vir Biotechnology was a new Virtu Financial position in Q1 2026.
  • Vir Biotechnology made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #988 holding.
  • Virtu Financial first reported a position in Vir Biotechnology in Q2 2020 and has held it in 7 quarters since.
  • Virtu Financial's Vir Biotechnology position peaked at $955K in Q2 2020.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.